Prognostic value of body composition out of PSMA-PET/CT in prostate cancer patients undergoing PSMA-therapy
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-025-07416-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Wolfgang Roll und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Münster, Münster, Germany. wolfgang.roll@ukmuenster.de. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Body Composition, Prostatic Neoplasms, Castration-Resistant, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Münster.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
This retrospective study aims to develop a deep learning-based approach to whole-body CT segmentation out of standard PSMA-PET-CT to assess body composition in metastatic castration resistant prostate cancer (mCRPC) patients prior to [ 177 Lu]Lu-PSMA radioligand therapy (RLT). Our goal is to go beyond standard PSMA-PET-based pretherapeutic assessment and identify additional body composition metrics out of the CT-component, with potential prognostic value.
Methods
We used a deep learning segmentation model to perform fully automated segmentation of different tissue compartments, including visceral- (VAT), subcutaneous- (SAT), intra/intermuscular- adipose tissue (IMAT) from [ 68 Ga]Ga-PSMA-PET-CT scans of n = 86 prostate cancer patients before RLT. The proportions of different adipose tissue compartments to total adipose tissue (TAT) assessed on a 3D CT-volume of the abdomen or on a 2D single slice basis (centered at third lumbal vertebra (L3)) were compared for their prognostic value. First, univariate and multivariate Cox proportional hazards regression analyses were performed. Subsequently, the subjects were dichotomized at the median tissue composition, and these subgroups were evaluated by Kaplan–Meier analysis with the log-rank test.
Results
The automated segmentation model was useful for delineating different adipose tissue compartments and skeletal muscle across different patient anatomies. Analyses revealed significant correlations between lower SAT and higher IMAT ratios and poorer therapeutic outcomes in Cox regression analysis (SAT/TAT: p = 0.038; IMAT/TAT: p < 0.001) in the 3D model. In the single slice approach only IMAT/SAT was significantly associated with survival in Cox regression analysis ( p < 0.001; SAT/TAT: p > 0.05). IMAT ratio remained an independent predictor of survival in multivariate analysis when including PSMA-PET and blood-based prognostic factors.
Conclusions
In this proof-of-principle study the implementation of a deep learning-based whole-body analysis provides a robust and detailed CT-based assessment of body composition in mCRPC patients undergoing RLT. Potential prognostic parameters have to be corroborated in larger prospective datasets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Hospital Münster, Münster, Germany. wolfgang.roll@ukmuenster.de.
- West German Cancer Centre, Münster, Germany. wolfgang.roll@ukmuenster.de.
- Institute of Medical Informatics, University of Münster, Münster, Germany.
- Department of Nuclear Medicine, University Hospital Münster, Münster, Germany.
- West German Cancer Centre, Münster, Germany.
- Department of Radiology, University Hospital Münster, Münster, Germany.
ORCID-Profile: Wolfgang Roll
Förderung
- Universitätsklinikum Münster
Zitieren
APA
Roll, W., Plagwitz, L., Ventura, D., Masthoff, M., Backhaus, C., Varghese, J., Rahbar, K., & Schindler, P. (2025). Prognostic value of body composition out of PSMA-PET/CT in prostate cancer patients undergoing PSMA-therapy. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07416-7
Vancouver
Roll W, Plagwitz L, Ventura D, Masthoff M, Backhaus C, Varghese J, et al. Prognostic value of body composition out of PSMA-PET/CT in prostate cancer patients undergoing PSMA-therapy. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07416-7
BibTeX
@article{Roll2025,
author = {Roll, Wolfgang and Plagwitz, Lucas and Ventura, David and Masthoff, Max and Backhaus, Clemens and Varghese, Julian and Rahbar, Kambiz and Schindler, Philipp},
title = {Prognostic value of body composition out of PSMA-PET/CT in prostate cancer patients undergoing PSMA-therapy},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-025-07416-7}
}
EUVIMED